Please wait while the page is loading...

loader

Sector

Patents

Australian IP Report 2026: Businesses with IP see stronger productivity, income growth

Australian IP Report 2026: Businesses with IP see stronger productivity, income growth

13 May 2026

Global innovation networks are fragmenting, domestic IP activity remains resilient.

UK IP Office outlines AI push, fee increases in 2026-27 plan

UK IP Office outlines AI push, fee increases in 2026-27 plan

13 May 2026

Modernization drive targets digital services, innovation and support for smaller businesses.

INTA 2026: Singapore pushes IP to the centre of its innovation economy

INTA 2026: Singapore pushes IP to the centre of its innovation economy

06 May 2026

Singapore is doubling down on intellectual property as a strategic economic asset, arguing that patents, trademarks and other intangible rights are no longer peripheral legal matters but core drivers of growth, jobs and global competitiveness.

INTA 2026: Lawyers urge companies to align trademarks, patents and their brands

INTA 2026: Lawyers urge companies to align trademarks, patents and their brands

06 May 2026

Expert: ‘You don’t have to trademark everything all over the world, but even for startups, get something on file.’

When does public display become prior art: Anticipation under the Patents Act, 1970

When does public display become prior art: Anticipation under the Patents Act, 1970

15 March 2026

Section 31 of India’s Patents Act, 1970, provides exceptions to the requirement for novelty, including anticipation by public display.

2026 Asia IP’s editorial team reveals China’s top IP firms, practices

2026 Asia IP’s editorial team reveals China’s top IP firms, practices

30 April 2026

China’s concerted efforts to improve the protection of intellectual property rights have fuelled the country’s rise to become one of the world’s top economies.

The human denominator: Why AI’s creativity tests the limits of ownership

The human denominator: Why AI’s creativity tests the limits of ownership

29 April 2026

AI is rapidly transforming creative work, but is it a rival or a partner to human imagination? — Cathy Li

Dual pathways: Optimizing industrial design protection strategy in Russia and Eurasia

Dual pathways: Optimizing industrial design protection strategy in Russia and Eurasia

22 April 2026

The choice between Russian and Eurasian procedures to register industrial designs may depend on the applicant’s strategy for expanding design protection.

Delhi High Court to copyright office: Decide on Thaler application for AI artwork in eight weeks

Delhi High Court to copyright office: Decide on Thaler application for AI artwork in eight weeks

20 April 2026

Decision will help determine whether AI-generated works can have copyright protection in India.

Who is liable when agentic AI violates a patent?

Who is liable when agentic AI violates a patent?

15 March 2026

Agentic AI has moved beyond simply following instructions. — Excel V. Dyquiangco

Vietnam’s amended IP Law takes effect on April 1, 2026

Vietnam’s amended IP Law takes effect on April 1, 2026

15 April 2026

The amendments address modern IP challenges.

Chinese drone company accuses rival of patent infringement

Chinese drone company accuses rival of patent infringement

01 April 2026

Former engineers’ work at rival company sparks patent dispute and uncertainty.

Main differences in the patent legislation of Russia and Kazakhstan

Main differences in the patent legislation of Russia and Kazakhstan

31 March 2026

Applicants may find advantages to a combined approach to patenting, using the laws of Kazakhstan and Russia to their advantage.

GUIs as registrable designs in India: From UST Global to the 2026 clarification

GUIs as registrable designs in India: From UST Global to the 2026 clarification

28 February 2026

In a landmark ruling, the Calcutta High Court has held that a graphical user interface can qualify for registration as a design under the Designs Act, 2000.

Ozempic patent expiry opens door for generics in India, China, Canada

Ozempic patent expiry opens door for generics in India, China, Canada

20 March 2026

Patent lapse opens pathway for more affordable diabetes and obesity treatments.